Brazil suspends $320 million deal with Bharat Biotech for Covaxin
3 years, 5 months ago

Brazil suspends $320 million deal with Bharat Biotech for Covaxin

Live Mint  

Brazil has suspended the contract for 20 million doses of Bharat Biotech International’s Covaxin worth about $320 million following a controversy over alleged irregularities in procurement and pricing. The contract between Bharat Biotech and Brazil’s Precisa Medicamentos has been at the centre of a political storm following a report by the parliamentary commission of inquiry on the Bolsonaro administration’s handling of the pandemic. Email exchanges between Bharat Biotech and the ministry showed an initial quoted price of $1.34 per dose, which later rose to $15 per dose after the contract was negotiated, according to a Parliamentary Inquiry Committee statement, the report said. In a statement on Wednesday, Bharat Biotech said it had committed no wrong in the supply contract for the covid vaccine, including the pricing, which was set at $15-20 for export markets.

Contract Bharat Bharat Biotech Biotech Covaxin Brazil Suspends Million Dose  contract  pricing  vaccine  covaxin  price  320  biotech  report  million  dose  statement  bharat  brazil  suspends  deal

History of this topic

Covid: 250 million Corbevax, Covaxin in stock, ready for dispatch
1 year, 11 months ago

Covid: 250 million Corbevax, Covaxin in stock, ready for dispatch

Hindustan Times  

Around 250 million Covid vaccines manufactured by two major Hyderabad-based units – Biological E and Bharat Biotech – are ready for dispatch in the market as soon as orders are received. Nearly 200 million Corbevax vaccine of Biological E and 50 million of Bharat Biotech's Covaxin are stockpiled at the moment. Read| Covid drills at hospitals; case count remains low …

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses
1 year, 11 months ago

Biological E, Bharat Biotech Together Sitting on Stockpile of 250 Million Covid Vaccine Doses

News 18  

Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of Covid-19 vaccines ready to dispatch as and when orders are received. According to respective company sources, Biological E is holding 200 million doses of its Covid-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses …

Covid: Biological E, Bharat Biotech together holding 250 million vaccine doses
1 year, 11 months ago

Covid: Biological E, Bharat Biotech together holding 250 million vaccine doses

Live Mint  

The two major Hyderabad-based vaccine manufacturing units, Biological E and Bharat Biotech, together are holding about 250 million Covid vaccine doses ready to dispatch as and when orders are received, according to news agency PTI. Currently, Biological E is holding 200 million doses of its Covid-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses …

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses
1 year, 11 months ago

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses

India TV News  

As Covid cases are increasing in the country, now focus is back on vaccination drive. According to sources- two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together have about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received. Corbevax and Covaxin stocks Biological E held 200 million doses of its …

50 million doses of Covaxin set to expire early 2023 due to poor offtake
2 years, 1 month ago

50 million doses of Covaxin set to expire early 2023 due to poor offtake

The Hindu  

Nearly 50 million doses of Bharat Biotech’s COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers owing to poor demand, company sources said. Due to lack of product demand, production stoppage of Covaxin - a two dose jab, was initiated by Bharat Biotech earlier this year, though the vaccine maker …

COVID: 50 million Covaxin doses set to expire early 2023 due to poor off take
2 years, 1 month ago

COVID: 50 million Covaxin doses set to expire early 2023 due to poor off take

India TV News  

Highlights Covaxin lying with the firm are set to expire early next year There are no takers owing to poor demand, said company sources India reported 1,082 fresh COVID-19 cases on Saturday Covaxin news: Nearly 50 million doses of Bharat Biotech’s COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers …

GAVI financing to allow for immediate funds for next pandemic
2 years, 3 months ago

GAVI financing to allow for immediate funds for next pandemic

Live Mint  

Global vaccine alliance GAVI has set up financial instruments that will allow the group to immediately access pledged donor funding if it needs to buy vaccines for future pandemics, Chief Executive Seth Berkley told Reuters. Berkley said that in 2020 and 2021, GAVI was limited in its ability to buy COVID-19 vaccines because even though donors had committed $2.4 billion, …

Serum Institute to Give Free Covishield Vials to Private Vaccination Centres to Compensate for Price Difference
2 years, 8 months ago

Serum Institute to Give Free Covishield Vials to Private Vaccination Centres to Compensate for Price Difference

News 18  

A day after slashing the price of the precaution dose of Covishield to Rs 225 per shot for private hospitals, the Serum Institute of India told the Centre on Sunday that it will compensate for the price difference for the unexpired stocks lying with private centres in the form of free vials of fresh stocks, official sources said. Vaccine majors …

Covishield, Covaxin to now cost private hospitals Rs 225 per dose
2 years, 8 months ago

Covishield, Covaxin to now cost private hospitals Rs 225 per dose

India Today  

A single dose of the Serum Institute of India's Covishield and Bharat Biotech's Covaxin will now cost private hospitals Rs 225. Adar Poonawalla, CEO of SII, said in a tweet on Saturday that the vaccine maker has decided to slash the prices of the Covid-19 jab for private hospitals from Rs 600 to Rs 225 after consultation with the central …

WHO suspends UN supply of Covaxin over manufacturing deficiencies, Bharat Biotech slows down production
2 years, 8 months ago

WHO suspends UN supply of Covaxin over manufacturing deficiencies, Bharat Biotech slows down production

India Today  

In a setback to India’s indigenous vaccine against Covid-19, the World Health Organisation has issued a statement saying that the body is suspending the supply of Bharat Biotech’s Covaxin through UN agencies. A day earlier, Bharat Biotech issued a statement saying the company “announces the temporary slowing down of production of Covaxin across its manufacturing facilities, having completed its supply …

Bharat Biotech says upgrading Covaxin facilities as WHO suspends vaccine supplies
2 years, 8 months ago

Bharat Biotech says upgrading Covaxin facilities as WHO suspends vaccine supplies

India TV News  

Highlights The WHO has suspended the supply of Covaxin vaccine under the United Nations procurement The development comes after an inspection of the COVID-19 vaccine last month Earlier too, Bharat Biotech had said it is working on further improvements and upgrades Bharat Biotech has said it is working on upgrades to ensure that the production of Covaxin continues to meet …

WHO pauses Covaxin supply via UN bodies
2 years, 8 months ago

WHO pauses Covaxin supply via UN bodies

The Hindu  

Bharat Biotech to upgrade facility The World Health Organisation on Saturday suspended supply of Bharat Biotech’s COVID vaccine, Covaxin, to allow the manufacturer to upgrade facilities and address deficiencies found during an inspection last month. ‘Will meet standards’ In a statement issued on April 1, Bharat Biotech said it was fully committed to implementing facility improvements and upgrades to ensure …

WHO suspends Covaxin supply to UN agencies
2 years, 8 months ago

WHO suspends Covaxin supply to UN agencies

Deccan Chronicle  

Hyderabad: The World Health Organization has confirmed it has suspended the supply of Covaxin, produced by city-based Bharat Biotech, through UN procurement agencies and recommending to countries that received the covid vaccine to take actions as appropriate. A statement issued by WHO on Saturday said the suspension is in response to the outcomes of its post EUL inspection held between …

WHO suspends international supply of Covaxin via UN procurement
2 years, 8 months ago

WHO suspends international supply of Covaxin via UN procurement

India Today  

The World Health Organization in a statement issued on April 2 confirmed the suspension of supply of Covaxin produced by Bharat Biotech, through UN procurement agencies and gave recommendation to the countries that received the vaccine to take actions as appropriate. On April 1, the Indian vaccine manufacturer Bharat Biotech issued a statement announcing the “temporary slowing down of Covaxin …

Rich countries getting new COVID vaccine before poorer ones
2 years, 9 months ago

Rich countries getting new COVID vaccine before poorer ones

Associated Press  

NEW DELHI — The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the U.N.-backed effort to supply poorer countries, a sign that inequity persists in the global response to the pandemic. The company, Novavax, got $388 million from one …

Two COVID vaccines may cost Rs. 275 after market nod
2 years, 10 months ago

Two COVID vaccines may cost Rs. 275 after market nod

Deccan Chronicle  

NEW DELHI: In a bid to make vaccines against Covid-19 affordable, prices of Covishield and Covaxin jabs are likely to be capped at Rs 275 per dose, with an additional service charge of Rs 150. Serum Institute of India director Prakash Kumar Singh had submitted an application to the DCGI on October 25 seeking regular market approval for its Covishield …

Each Dose of Covishield, Covaxin Likely to be Capped at Rs 275 After Getting Regular Market Approval
2 years, 10 months ago

Each Dose of Covishield, Covaxin Likely to be Capped at Rs 275 After Getting Regular Market Approval

News 18  

The price of Covishield and Covaxin, the Covid vaccines which are expected to soon get regular market approval from India's drug regulator, is likely to be capped at Rs 275 per dose plus an additional service charge of Rs 150, official sources said. A Subject Expert Committee on Covid-19 of the Central Drugs Standard Control Organisation on January 19 recommended …

Each dose of Covishield, Covaxin likely to be capped at Rs 275 upon market approval
2 years, 10 months ago

Each dose of Covishield, Covaxin likely to be capped at Rs 275 upon market approval

India TV News  

Highlights The price of Covishield and Covaxin is expected to soon come down. They are likely to be capped at Rs 275 per dose plus an additional service charge of Rs 150. The price of Covishield and Covaxin, the Covid vaccines which are expected to soon get regular market approval from India's drug regulator, is likely to be capped at …

Panel pitches full market nod for Covaxin, Covishield
2 years, 11 months ago

Panel pitches full market nod for Covaxin, Covishield

Hindustan Times  

The subject expert panel of the national drugs regulator on Wednesday recommended full market authorisation for both Covaxin and Covishield under certain conditions, according to people familiar with the developments. Serum Institute of India and Bharat Biotech International Ltd, manufacturers of Covishield and Covaxin respectively, separately applied to the central drugs standard control organisation to seek full market authorisation stating …

Gavi and Bharat Biotech discuss possible COVAX use of Covaxin
2 years, 11 months ago

Gavi and Bharat Biotech discuss possible COVAX use of Covaxin

Live Mint  

The Gavi vaccine alliance is in talks with India's Bharat Biotech over potential procurement of the company's Covaxin COVID-19 shot for the COVAX global vaccine distribution programme, a Gavi spokesperson told Reuters on Thursday. The World Health Organization in November gave Covaxin, India's first homegrown COVID-19 vaccine, approval for emergency use. Gavi said it was also working with the Serum …

COVID-19: India supplies 5 lakh more Covaxin doses to Afghanistan
2 years, 11 months ago

COVID-19: India supplies 5 lakh more Covaxin doses to Afghanistan

Deccan Chronicle  

New Delhi: Bharat Biotech on Monday informed that India has supplied another batch of humanitarian assistance consisting of 5,00,000 doses of COVID-19 vaccine, Covaxin to Afghanistan. Taking to Twitter, Bharat Biotech said, "Today, India supplied the next batch of humanitarian assistance consisting of 5,00,000 doses of COVID vaccine to Afghanistan. The last batch of humanitarian assistance consisting of 5,00,000 doses …

Bharat Biotech to donate 2 lakh doses of covaxin to Vietnam
3 years ago

Bharat Biotech to donate 2 lakh doses of covaxin to Vietnam

Live Mint  

Bharat Biotech will donate 2,00,000 doses of covaxin to The Republic of Vietnam, the Hyderabad based pharmaceutical company said on Thursday. This donation represents a gesture of goodwill to provide access to Bharat Biotech World Health Organization approved, indigenously developed covaxin to fight the covid-19 pandemic across borders, Suchitra Ella, Joint Managing Director of Bharat Biotech said. Bharat Biotech was …

India’s Serum Institute resumes vaccine exports to COVAX
3 years ago

India’s Serum Institute resumes vaccine exports to COVAX

Al Jazeera  

The world’s largest vaccine maker halted shipments of COVID shots in March as India saw an explosion in infections. The Serum Institute of India, the world’s largest vaccine maker, has resumed exports of coronavirus vaccines to the UN-backed COVAX distribution programme after halting most overseas sales in March. At the time, Serum Institute had contracts to provide COVAX with 200 …

Why Bharat Biotech’s Covaxin Failed to be the Hero of India’s Fight Against Covid-19
3 years, 2 months ago

Why Bharat Biotech’s Covaxin Failed to be the Hero of India’s Fight Against Covid-19

News 18  

Complex processes, scattered production units, need for more safety zones and shortage of skilled staffers are some of the top reasons that restricted Bharat Biotech’s Covaxin from becoming the poster-boy of India’s vaccination story against Covid-19. On January 4, Bharat Biotech’s managing director Dr Krishna Ella had said in a virtual press briefing that the company is aiming to manufacture …

Bharat Biotech completes phase 2/3 trials of Covaxin in children, to submit data by next week
3 years, 3 months ago

Bharat Biotech completes phase 2/3 trials of Covaxin in children, to submit data by next week

Hindustan Times  

Bharat Biotech, the Hyderabad-based biotechnology company and the makers of Covaxin Covid-19 vaccine, on Tuesday said that the phase 2/3 trials of Covaxin for inoculation in children under the age of 18 are over. Briefing on the production of Covaxin, Krishna Ella said that it would reach 55 million doses in October. Bharat Biotech’s chairman and managing director Krishna Ella …

A spike: The Hindu Editorial on records and COVID-19 vaccination coverage
3 years, 3 months ago

A spike: The Hindu Editorial on records and COVID-19 vaccination coverage

The Hindu  

India on September 17 administered a record 2.5 crore vaccine shots, which an ebullient Health Ministry said was the equivalent of the populations of the whole of Australia, two-thirds of Canada and five times that of New Zealand. The only other comparison would be China’s pace of vaccination — 2.47 crore shots on a single day. Since the vaccination drive …

Back of the line: Charity only goes so far in world vaccines
3 years, 4 months ago

Back of the line: Charity only goes so far in world vaccines

Associated Press  

LONDON — When global health officials created COVAX, a U.N.-backed effort to share coronavirus vaccines, it was supposed to guarantee the world’s most vulnerable people could get doses without being at the mercy of unreliable donations. But they decided against blocking rich countries from getting more vaccines, reasoning that without them, “it would be difficult to secure deals with some …

Covishield, Covaxin to drive India's 136-crore vaccine dose goal between August and December
3 years, 4 months ago

Covishield, Covaxin to drive India's 136-crore vaccine dose goal between August and December

India Today  

The government has said that more than 136 crore doses of Covid-19 vaccines are expected to be available in India in the next four months with Covishield and Covaxin driving the country’s vaccination programme. VACCINE PRODUCTION PROJECTION TILL DECEMBER: AUGUST Covaxin - 3.15 crore Covishield - 23 crore Total doses - 26.15 crore OCTOBER, NOVEMBER AND DECEMBER: Covaxin - 5.25 …

Bharat Biotech rejects charges that some batches of Covaxin weren't of 'right quality', slowed supply
3 years, 4 months ago

Bharat Biotech rejects charges that some batches of Covaxin weren't of 'right quality', slowed supply

India Today  

Days after some media reports raised concerns over the quality of some batches of Bharat Biotech's Covaxin, the vaccine manufacturer has issued a clarification saying all its vaccine batches are subjected to over 200 quality control checks. Recently, some media reports had claimed that supply of Covaxin were slowed down because the first few batches of the vaccine produced at …

Initial hiccups in Bharat Biotech Bengaluru plant delayed Covaxin production: NTAGI Chief
3 years, 4 months ago

Initial hiccups in Bharat Biotech Bengaluru plant delayed Covaxin production: NTAGI Chief

Live Mint  

New Delhi: India achieved the target of 47 crore COVID-19 vaccine doses till the month of July, Dr N K Arora, Chief of National Immunization Technical Advisory Group said and added that some hiccups like initial difficulties in the new Bangalore plant of Bharat Biotech had delayed the production of Covaxin. Dr NK Arora also said that Bharat Biotech will …

Brazil defers import of Covaxin after Bharat Bioetch terminates pact with local partners
3 years, 4 months ago

Brazil defers import of Covaxin after Bharat Bioetch terminates pact with local partners

Firstpost  

The decision comes in the wake of the MoU between Bharat Biotech and the Brazilian government for the supply of 20 million doses of Covaxin landed in controversy and attracted investigation by authorities Hyderabad: After suspending the proposed clinical trials of Bharat Bioetch’s COVID-19 vaccine Covaxin and a request for Emergency Use Authorisation, Brazil now has suspended its decision to …

Brazil suspends clinical trials of Covaxin after Bharat Biotech terminates vaccine deal
3 years, 5 months ago

Brazil suspends clinical trials of Covaxin after Bharat Biotech terminates vaccine deal

India Today  

Brazil has suspended the clinical studies of Bharat Biotech's Covid-19 vaccine Covaxin after termination of the company's agreement with its partner, as per reports. "The suspension was carried out as a result of a statement from the Indian company Bharat Biotech Limited International, sent to Anvisa on Friday," the Brazilian health regulator said on Friday. Notwithstanding such termination, Bharat Biotech …

Covaxin Production to be Increased to 5.8 Crore Doses a Month Soon, Health Ministry Says
3 years, 5 months ago

Covaxin Production to be Increased to 5.8 Crore Doses a Month Soon, Health Ministry Says

News 18  

The government told Parliament on Tuesday that it has received 5.45 crore doses of Bharat Biotech’s Covaxin in over six months till July 16. The government said the company has communicated that it will be increasing its monthly production to 5.8 crore doses soon. The current average monthly capacity of production of Covishield by Serum Institute of India is 11 …

ICMR clueless about total development cost of Covaxin, reveals RTI
3 years, 5 months ago

ICMR clueless about total development cost of Covaxin, reveals RTI

India Today  

The Indian Council of Medical Research has no clue about the total development cost of Covaxin, India's indigenous Covid-19 vaccine made by Bharat Biotech Limited, an RTI query has revealed. To find answers to the development and manufacturing cost of Covaxin, India Today filed a Right to Information request with ICMR, which developed the vaccine in partnership with BBIL. ICMR …

Govt to procure 66 crore more doses of Covishield, Covaxin at revised rates
3 years, 5 months ago

Govt to procure 66 crore more doses of Covishield, Covaxin at revised rates

The Hindu  

The Centre has placed an order to procure 66 crore more doses of Covishield and Covaxin to be supplied between August and December this year, at a revised price of ₹ 205 and ₹ 215 per dose, respectively, excluding taxes, official sources said. "An order to procure 66 crore more doses of COVID-19 vaccines – Covishield and Covaxin – to …

Govt to procure 66 crore more doses of Covishield, Covaxin at revised rates
3 years, 5 months ago

Govt to procure 66 crore more doses of Covishield, Covaxin at revised rates

India TV News  

The Centre has placed an order to procure 66 crore more doses of Covishield and Covaxin to be supplied between August and December this year, at a revised price of Rs 205 and Rs 215 per dose, respectively, excluding taxes, official sources informed PTI. "An order to procure 66 crore more doses of COVID-19 vaccines--Covishield and Covaxin--to be supplied between …

Indian govt orders 66 crore covid vaccine doses in biggest procurement: Report
3 years, 5 months ago

Indian govt orders 66 crore covid vaccine doses in biggest procurement: Report

Live Mint  

The Indian government has ordered 660 million vaccine doses for August-December, its largest procurement, local news reports said on Friday, as state authorities and health experts warned that shortages could leave millions vulnerable if coronavirus infections surge again. The federal government aims to inoculate all of the country's estimated 944 million adults by December, a target health experts have said …

All documents required for emergency use listing of Covaxin submitted to WHO: Bharat Biotech
3 years, 5 months ago

All documents required for emergency use listing of Covaxin submitted to WHO: Bharat Biotech

India Today  

Bharat Biotech on Monday said that all documents required for Emergency Use Listing of Covaxin have been submitted to the World Health Organisation. WHO chief scientist Soumya Swaminathan had on Saturday said that the global health body is likely to take a decision on EUL of Bharat Biotech’s Covid-19 vaccine Covaxin within four to six weeks. Speaking at a webinar …

WHO chief calls for vaccinating atleast 10% of population of each country by Sept to control Covid
3 years, 5 months ago

WHO chief calls for vaccinating atleast 10% of population of each country by Sept to control Covid

India Today  

Voicing concern over many countries failing to vaccinate their people, WHO chief Dr Tedros Adhanom Ghebreyesus on Thursday called for vaccinating at least 10 per cent of the population of every country by September as he emphasised that vaccination is the best way to control the pandemic and reboot the global economy. Asserting that when some countries cannot vaccinate, it's …

Brazil suspends contract to buy 20 mn doses of Bharat Biotech’s Covaxin over alleged irregularities
3 years, 5 months ago

Brazil suspends contract to buy 20 mn doses of Bharat Biotech’s Covaxin over alleged irregularities

Live Mint  

Brazil has suspended its contract worth around $320 million for 20 million doses of Bharat Biotech International’s Covaxin following allegations over the covid-19 vaccine’s procurement and pricing of $15 per dose. Emails between Bharat Biotech and the ministry submitted to CPI showed an initial quoted price of $1.34 per dose, which later rose to $15 per dose in the negotiated …

'Covaxin pricing clearly established': Bharat Biotech clarifies on Brazil deal row
3 years, 5 months ago

'Covaxin pricing clearly established': Bharat Biotech clarifies on Brazil deal row

India TV News  

Bharat Biotech on Wednesday issued a clarification over the procurement process of Covaxin in Brazil and other countries. However, procurement happens only post EUA In order to secure a firm Purchase Order from the country, the company proceeds to raise a Pro Forma Invoice to the MOH, towards the supply of the vaccine Based on the invoice, the MOH pays …

Brazil to suspend Covaxin deal with Bharat Biotech over allegations of irregularities by President
3 years, 5 months ago

Brazil to suspend Covaxin deal with Bharat Biotech over allegations of irregularities by President

India TV News  

Brazil has announced to suspend the Covaxin deal with Hyderabad-based laboratory Bharat Biotech. Brazil had in February signed a deal with Bharat Biotech to procure 20 million doses of Covaxin for USD 324 million. The South America country's Health Ministry had to pay USD 15 per vaccine dose to Precisa Medicamentos, the representative of Bharat Biotech in Brazil. Precisa, however, …

Step-by-step approach followed, no advance payment: Bharat Biotech on Brazil Covaxin row
3 years, 5 months ago

Step-by-step approach followed, no advance payment: Bharat Biotech on Brazil Covaxin row

India Today  

In the wake of Brazil suspending a $324-million deal for Covaxin shots over allegations of graft, the vaccine’s manufacturer, Bharat Biotech, has denied any wrongdoing and claimed it followed a "step-by-step" approach to get regulatory approval in the South American country. “In the specific case of procurement of Covaxin by MOH Brazil, since the first meetings with MOH Brazil during …

Brazil to suspend COVID vaccine deal with India’s Bharat Biotech
3 years, 5 months ago

Brazil to suspend COVID vaccine deal with India’s Bharat Biotech

Al Jazeera  

Deal for 20 million doses of Bharat Biotech’s shot has become a headache for Bolsonaro on accusations of irregularities. Brazil will suspend a $324m Indian COVID-19 vaccine contract that has mired President Jair Bolsonaro in accusations of irregularities, the health minister said on Tuesday, following the guidance of the federal comptroller, the CGU. The deal to buy 20 million doses …

$324 million Covaxin deal row in Brazil explained
3 years, 5 months ago

$324 million Covaxin deal row in Brazil explained

India Today  

Brazilian politics is on the boil over a deal with Hyderabad-based Bharat Biotech for the supply of two crore doses of Covaxin, a Covid-19 vaccine that was developed in collaboration with the Indian Council of Medical Research in India. - The national auditor in Brazil recommended suspension of the deal with Bharat Biotech in the face of a row over …

Brazil suspends Bharat Biotech's Covaxin order over graft allegations
3 years, 5 months ago

Brazil suspends Bharat Biotech's Covaxin order over graft allegations

India Today  

The Brazilian government, which agreed to purchase 20 million doses of Bharat Biotechs Covid-19 vaccine Covaxin, on Wednesday announced suspension of the contract following allegations of irregularities in the deal. According to CGU's preliminary analysis, there are no irregularities in the contract, but, due to compliance, the @minsaude opted to suspend the contract for further analysis," Brazil Health Minister Marcelo …

Brazil’s Bolsonaro under fire after vaccine deal allegations
3 years, 5 months ago

Brazil’s Bolsonaro under fire after vaccine deal allegations

Associated Press  

BRASILIA, Brazil — Accusations that Brazilian President Jair Bolsonaro turned a blind eye to possible corruption in a deal to purchase coronavirus vaccines have heightened threats to his presidency, including a move to recommend slapping him with a criminal charge. Bolsonaro, who has been targeted by nationwide street protests in recent weeks, has called the Senate committee investigating the government’s …

Brazil probes vaccine contract with India’s Bharat Biotech
3 years, 6 months ago

Brazil probes vaccine contract with India’s Bharat Biotech

Al Jazeera  

Prosecutors cite the drug’s high price, speedy talks and pending regulatory approvals as red flags for the contract. Brazilian federal prosecutors have opened an investigation into a contract worth 1.6 billion reals for 20 million doses of a COVID-19 vaccine made by India’s Bharat Biotech, according to a document seen by Reuters. The prosecutor-general’s office cited comparatively high prices, speedy …

Brazil probes Health Ministry deal to buy Covaxin vaccine
3 years, 6 months ago

Brazil probes Health Ministry deal to buy Covaxin vaccine

Associated Press  

RIO DE JANEIRO — Brazil’s federal prosecutor’s office is investigating possible irregularities in a Health Ministry contract to purchase 20 million doses of the Covaxin vaccine manufactured by Indian laboratory Bharat Biotech. The agreement signed in February commits the ministry to pay $320 million - at a cost of $15 per vaccine dose - to Precisa Medicamentos, the representative of …

Discover Related